Literature DB >> 6282201

Derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin and their activity against susceptible and resistant Escherichia coli strains.

R G Werner, U L Lechner, H Goeth.   

Abstract

A number of alkyl and acyl derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin were tested against various Escherichia coli strains, possessing different susceptibilities to spectinomycin. The influence of the lipophilicity and the length of the side chain substituents of the derivatives was compared to both minimal inhibitory concentration values and stability to adenyltransferase. Derivatives with a chain length of more than 10 carbon atoms demonstrated a significantly higher activity against all investigated strains, whether susceptible or resistant. The same inhibitory effect was achieved with short-chain aminoacyl derivatives only against susceptible strains. Other short-chain derivatives possessed no advantage to spectinomycin. A 10-fold decrease in the affinity for adenyltransferase was achieved in compounds with a high lipophilicity (log P), i.e., in aliphatic substituted derivatives with a log P greater than 4 and in benzoyl-substituted derivatives with a log P greater than 2. Derivatives with branched alkyl chains and long side chains displayed a different mode of action than spectinomycin. They possessed strong activity against strains with an altered ribosomal binding site and a decreased influence of pH on antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282201      PMCID: PMC181835          DOI: 10.1128/AAC.21.1.101

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Calculation of hydrophobic constant (log P) from pi and f constants.

Authors:  A Leo; P Y Jow; C Silipo; C Hansch
Journal:  J Med Chem       Date:  1975-09       Impact factor: 7.446

2.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

3.  The tolerance of high dose intravenous spectinomycin therapy in man.

Authors:  E Novak; C A Schlagel; L A LeZotte; R T Pfeifer
Journal:  J Clin Pharmacol       Date:  1974 Aug-Sep       Impact factor: 3.126

4.  Ribosomal proteins. XXII. Studies on the altered protein S5 from a spectinomycin-resistant mutant of Escherichia coli.

Authors:  G Funatsu; K Nierhaus; B Wittmann-Liebold
Journal:  J Mol Biol       Date:  1972-02-28       Impact factor: 5.469

5.  The treatment of gonorrhea with spectinomycin and rifampicin.

Authors:  R Labowitz; W L Porter; W J Holloway
Journal:  Del Med J       Date:  1970-11

6.  Ribosomal protein conferring sensitivity to the antibiotic spectinomycin in Escherichia coli.

Authors:  A Bollen; J Davies; M Ozaki; S Mizushima
Journal:  Science       Date:  1968-07-04       Impact factor: 47.728

7.  Chromosomal location of antibiotic resistance genes in Neisseria gonorrhoeae.

Authors:  G Biswas; S Comer; P F Sparling
Journal:  J Bacteriol       Date:  1976-03       Impact factor: 3.490

8.  Activity of spectinomycin against anaerobes.

Authors:  J E Rosenblatt; A M Gerdts
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

9.  Inactivation of dihydrostreptomycin and spectinomycin by Staphylococcus aureus.

Authors:  H Kawabe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

10.  Spectinomycin modification. III Chloro-deoxy analogs.

Authors:  R E Carney; W Rosenbrook
Journal:  J Antibiot (Tokyo)       Date:  1977-11       Impact factor: 2.649

View more
  1 in total

1.  Nocardia asteroides infection of the cauda equina.

Authors:  S J Brecker; C D Pugey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.